Circulating Biomarkers in Neuromuscular Disorders: What Is Known, What Is New

The urgent need for new therapies for some devastating neuromuscular diseases (NMDs), such as Duchenne muscular dystrophy or amyotrophic lateral sclerosis, has led to an intense search for new potential biomarkers. Biomarkers can be classified based on their clinical value into different categories:...

Descripción completa

Detalles Bibliográficos
Autores principales: Barp, Andrea, Ferrero, Amanda, Casagrande, Silvia, Morini, Roberta, Zuccarino, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393752/
https://www.ncbi.nlm.nih.gov/pubmed/34439911
http://dx.doi.org/10.3390/biom11081246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393752/
https://www.ncbi.nlm.nih.gov/pubmed/34439911
http://dx.doi.org/10.3390/biom11081246

Ejemplares similares